Correlation Between Lucid Diagnostics and Pulmonx Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lucid Diagnostics and Pulmonx Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lucid Diagnostics and Pulmonx Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lucid Diagnostics and Pulmonx Corp, you can compare the effects of market volatilities on Lucid Diagnostics and Pulmonx Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lucid Diagnostics with a short position of Pulmonx Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lucid Diagnostics and Pulmonx Corp.

Diversification Opportunities for Lucid Diagnostics and Pulmonx Corp

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lucid and Pulmonx is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Lucid Diagnostics and Pulmonx Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmonx Corp and Lucid Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lucid Diagnostics are associated (or correlated) with Pulmonx Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmonx Corp has no effect on the direction of Lucid Diagnostics i.e., Lucid Diagnostics and Pulmonx Corp go up and down completely randomly.

Pair Corralation between Lucid Diagnostics and Pulmonx Corp

Given the investment horizon of 90 days Lucid Diagnostics is expected to generate 0.76 times more return on investment than Pulmonx Corp. However, Lucid Diagnostics is 1.31 times less risky than Pulmonx Corp. It trades about 0.05 of its potential returns per unit of risk. Pulmonx Corp is currently generating about 0.01 per unit of risk. If you would invest  88.00  in Lucid Diagnostics on September 1, 2024 and sell it today you would earn a total of  12.00  from holding Lucid Diagnostics or generate 13.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lucid Diagnostics  vs.  Pulmonx Corp

 Performance 
       Timeline  
Lucid Diagnostics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lucid Diagnostics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Lucid Diagnostics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Pulmonx Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmonx Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Pulmonx Corp is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Lucid Diagnostics and Pulmonx Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lucid Diagnostics and Pulmonx Corp

The main advantage of trading using opposite Lucid Diagnostics and Pulmonx Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lucid Diagnostics position performs unexpectedly, Pulmonx Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmonx Corp will offset losses from the drop in Pulmonx Corp's long position.
The idea behind Lucid Diagnostics and Pulmonx Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world